Ofloxacinum
Floxal contains the active substance ofloxacin, which belongs to a group of antibacterial medicines called fluoroquinolones. The medicine has antibacterial effects on certain aerobic and anaerobic bacteria.
The medicine is used to treat infections of the anterior segment of the eye, caused by microorganisms sensitive to ofloxacin, such as bacterial conjunctivitis, keratitis, blepharitis, dacryocystitis, hordeolum, and corneal ulcer.
Before starting to use Floxal, the patient should discuss it with their doctor or pharmacist, especially in the following situations:
In case of skin rash or any other allergic reaction to Floxal eye drops, the patient should stop using the medicine and contact their doctor.
The doctor will decide on the appropriate treatment.
During the use of Floxal, the patient should avoid excessive exposure to sunlight or ultraviolet radiation (e.g., quartz lamps, solarium, etc.) due to the possibility of photosensitivity reactions.
Prolonged use of Floxal may lead to the multiplication of pathogenic microorganisms that are resistant to this medicine. In such a case, the doctor will decide on the appropriate treatment.
Swelling and tendon rupture have occurred in people taking fluoroquinolones orally or intravenously, especially in older patients and those treated with corticosteroids at the same time. The patient should stop using Floxal if they experience pain or swelling of the tendon (tendinitis).
The use of Floxal in children under 1 year of age is not recommended, as its safety and efficacy in this age group have not been established.
Due to the lack of sufficient data, the use of Floxal eye drops in newborns with conjunctivitis is not recommended.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
If Floxal eye drops are used at the same time as other eye drops or ointments, the patient should keep a 15-minute interval between the administration of the medicines. Eye ointment should always be used last.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
The doctor will decide whether the patient can use Floxal eye drops.
Ofloxacin had no effect on fertility in animals.
Immediately after administering the drops to the conjunctival sac, the patient may experience temporary, transient blurred vision. The patient should not drive or operate machines until the symptoms have completely resolved.
The medicine contains 0.000843 mg of benzalkonium chloride per drop, which corresponds to 0.025 mg/1 ml.
Benzalkonium chloride may be absorbed by soft contact lenses and change their color. The patient should remove their contact lenses before administering the drops and wait at least 15 minutes before putting them back on.
Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or corneal disorders (the transparent layer at the front of the eye). If the patient experiences any abnormal sensations in the eye, stinging, or eye pain after using the medicine, they should contact their doctor.
This medicine should always be used exactly as the doctor or pharmacist has told the patient. If the patient is unsure, they should ask their doctor or pharmacist.
Recommended dose
On average, 1 drop 4 times a day.
Instill into the conjunctival sac of the infected eye.
Instructions for administering the medicine:
Having someone else help or using a mirror may make it easier to administer the medicine.
Floxal eye drops are a sterile medicine. To avoid contamination, do not touch the dropper tip with your fingers or let it touch the surface of the eye or any other surface.
Using contaminated drops can lead to serious eye damage, including vision loss.
Treatment with Floxal eye drops should not last longer than 2 weeks.
If the infection worsens or does not improve after a few days, the patient should contact their doctor.
In case of using more than the recommended dose, the patient should rinse their eye with clean water.
If the medicine is accidentally ingested, the patient should contact their doctor immediately.
If the patient misses a dose of Floxal, they should use the medicine as soon as possible.
However, if it is almost time for the next dose, the patient should skip the missed dose and continue using the medicine according to the schedule prescribed by their doctor. The patient should not use a double dose to make up for the missed dose. If the patient misses several doses, they should inform their doctor and follow their advice.
Floxal should be used according to the doctor's instructions.
If the patient has any further doubts about using this medicine, they should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
In addition, the following side effects may occur:
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl.
By reporting side effects, it is possible to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Do not store above 25°C. Store in the original packaging to protect from light.
Any remaining drops should be discarded 6 weeks after first opening the bottle.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer need. This will help protect the environment.
The active substance of Floxal is ofloxacin. 1 ml of the solution contains 3 mg of ofloxacin (Ofloxacinum).
1 drop of the solution contains 100 micrograms (0.1 mg) of ofloxacin.
The other ingredients are: benzalkonium chloride, sodium chloride, hydrochloric acid 1N, and sodium hydroxide 1N (to adjust the pH), water for injections.
Floxal is available as eye drops.
The available packaging of the medicine is a white plastic bottle with a dropper and cap, containing 5 ml of eye drops, placed in a cardboard box.
For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
Bausch + Lomb Ireland Limited
3013 Lake Drive, Citywest Business Campus
Dublin 24, D24PPT3, Ireland
Dr. Gerhard Mann Chem.-Pharm. Fabrik GmbH
Brunsbuetteler Damm 165/173
13581 Berlin
Germany
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in Bulgaria, the country of export:20060871
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.